BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15371875)

  • 1. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
    Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
    J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.
    Kamiya N; Kishimoto T; Suzuki H; Sekita N; Nagai Y; Oosumi N; Kito H; Tochigi N; Shinbo M; Nemori R; Ichikawa T; Igarashi T; Ito H; Ishikura H
    Int J Cancer; 2003 Sep; 106(4):480-485. PubMed ID: 12845641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
    Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
    Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.
    Kaji M; Moriyama S; Sasaki H; Saitoh Y; Kiriyama M; Fukai I; Yamakawa Y; Mitsui A; Toyama T; Nemori R; Fujii Y
    Lung Cancer; 2003 Feb; 39(2):125-30. PubMed ID: 12581563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of matrix metalloproteinase-2 (MMP-2) activity with film in situ zymography for improved cytological diagnosis of breast tumors.
    Fujiwara A; Shibata E; Terashima H; Shishido A; Nishiki J; Yoshida K; Miyauchi K; Madachi A; Matsuura N
    Breast Cancer; 2006; 13(3):272-278. PubMed ID: 16929121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of active gelatinolytic sites in uterine endometrioid adenocarcinoma using film in situ zymography: association of stronger gelatinolysis with myometrial invasion.
    Zheng K; Nagai Y; Kishimoto T; Yamazawa K; Tate S; Nemori R; Hirai Y; Sekiya S; Ishikura H
    Jpn J Cancer Res; 2002 May; 93(5):516-22. PubMed ID: 12036447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
    Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
    J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
    Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
    Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin.
    Mook OR; Van Overbeek C; Ackema EG; Van Maldegem F; Frederiks WM
    J Histochem Cytochem; 2003 Jun; 51(6):821-9. PubMed ID: 12754293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.
    Koyama H; Iwata H; Kuwabara Y; Iwase H; Kobayashi S; Fujii Y
    Eur J Cancer; 2000 Oct; 36(16):2164-70. PubMed ID: 11044656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells.
    Li YL; Sato M; Kojima N; Miura M; Senoo H
    Cell Struct Funct; 1999 Oct; 24(5):255-61. PubMed ID: 15216880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.